ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

ClinicalTrials.gov ID: NCT00106184

Public ClinicalTrials.gov record NCT00106184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 5:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Rituximab Therapy in Refractory Adult and Juvenile Idiopathic Inflammatory Myopathy (IIM)

Study identification

NCT ID
NCT00106184
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Pittsburgh
Other
Enrollment
200 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Rituximab Drug

Drug

Eligibility (public fields only)

Age range
5 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2006
Primary completion
Jan 31, 2010
Completion
Jul 31, 2010
Last update posted
Mar 3, 2015

2006 – 2010

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
University of Alabama Arthritis Intervention Program (Adult Site) Birmingham Alabama 35294
Phoenix Neurological Associates, LTD (Adult Site) Phoenix Arizona 85006
Cedars-Sinai Medical Center (Adult Site) Los Angeles California 90048
Stanford University (Adult Site) Stanford California 94305
Stanford University (Pediatric Site) Stanford California 94305
University of Miami School of Medicine (Adult Site) Miami Florida 33136
Miami Children's Hospital (Pediatric Site) Miami Florida 33155
University of Kansas Medical Center (Adult Site) Kansas City Kansas 66160
Kentucky Clinic (Adult Site) Lexington Kentucky 40536
National Institute of Health (Adult Site) Bethesda Maryland 20892
National Institute of Health (Pediatric Site) Bethesda Maryland 20892
Children's Hospital of Boston (Pediatric Site) Boston Massachusetts 02115
Beth Israel Deaconess Medical Center (Adult Site) Boston Massachusetts 02215
University of Michigan Health System (Adult Site) Ann Arbor Michigan 48109
Michigan State University (Adult and Pediatric Site) Grand Rapids Michigan 49546
Mayo Clinic (Adult Site) Rochester Minnesota 55905
Mayo Clinic (Pediatric Site) Rochester Minnesota 55905
North Shore Long Island Jewish Health System (Adult Site) Lake Success New York 11042
Hospital for Special Surgery (Adult Site) New York New York 10021
Duke University Medical Center (Pediatric Site) Durham North Carolina 27710
Cincinnati's Children's Hospital (Pediatric Site) Cincinnati Ohio 45229
Children's Hospital of Philadelphia (Pediatric Site) Philadelphia Pennsylvania 19104
University of Pennsylvania (Adult Site) Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh (Pediatric Site) Pittsburgh Pennsylvania 15213
University of Pittsburgh / UPMC (Adult Site) Pittsburgh Pennsylvania 15261
University of Texas Southwestern Medical Center (Adult) Dallas Texas 75390-8884
Medical College of Wisconsin / Froedtert Memorial Luthern Hospital (Adult Site) Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2015 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00106184 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →